The U.S. Food and Drug Administration said on Monday it is revising the labeling of all extended-release stimulants used to ...

FDA updates CAR T-cell therapy labels, easing monitoring requirements and expanding access for eligible patients in oncology.

The U.S. Food and Drug Administration is revising the labeling of all extended-release attention-deficit/hyperactivity ...

Obsessive-compulsive disorder (OCD) impacts approximately 2% of the global population, often preventing individuals from living life to their full potential. Optibrium, a leading developer of ...